IGC Pharma, Inc. (IGC) Financial Statements (2026 and earlier)
Company Profile
| Business Address |
10224 FALLS ROAD POTOMAC, MD 20854 |
| State of Incorp. | MD |
| Fiscal Year End | March 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 9/30/2025 MRQ | 3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 405 | 1,198 | 3,350 | 10,460 | 14,628 | 12,339 | |||
| Cash and cash equivalent | 405 | 1,198 | 3,196 | 10,460 | 14,548 | 7,258 | |||
| Short-term investments | 154 | 80 | 5,081 | ||||||
| Receivables | 34 | 39 | 107 | 125 | 175 | 133 | |||
| Inventory, net of allowances, customer advances and progress billings | 1,360 | 1,540 | 2,651 | 3,548 | 5,478 | 4,245 | |||
| Inventory | 1,360 | 1,540 | 2,651 | 3,548 | 5,478 | 4,245 | |||
| Prepaid expense | 10 | 41 | 72 | 170 | 4 | 259 | |||
| Asset, held-for-sale, not part of disposal group | 702 | 720 | |||||||
| Deposits current assets | 27 | ||||||||
| Other current assets | 342 | 115 | 262 | 336 | 196 | 180 | |||
| Other undisclosed current assets | 43 | 52 | 24 | 472 | 3,036 | 574 | |||
| Total current assets: | 2,896 | 3,705 | 6,466 | 15,111 | 23,517 | 17,757 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 98 | 198 | 326 | 450 | 488 | 574 | |||
| Property, plant, and equipment, after accumulated depreciation, depletion, and amortization | 3,220 | 3,695 | 8,213 | 9,419 | 10,840 | 9,780 | |||
| Long-term investments and receivables | 12 | 22 | |||||||
| Long-term investments | 12 | 22 | |||||||
| Intangible asset, including goodwill, after accumulated amortization | 1,852 | 1,616 | 1,170 | 917 | 407 | 252 | |||
| Intangible asset, excluding goodwill, after accumulated amortization | 1,852 | 1,616 | 1,170 | 917 | 407 | 252 | |||
| Other noncurrent assets | 681 | 688 | 1,003 | 937 | 603 | 610 | |||
| Other undisclosed noncurrent assets | (11) | ||||||||
| Total noncurrent assets: | 5,851 | 6,197 | 10,712 | 11,723 | 12,350 | 11,227 | |||
| TOTAL ASSETS: | 8,747 | 9,902 | 17,178 | 26,834 | 35,867 | 28,984 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 2,257 | 2,340 | 1,368 | 1,457 | 1,588 | 1,134 | |||
| Accounts payable | 883 | 773 | 530 | 981 | 476 | 762 | |||
| Accrued liabilities | 1,374 | 1,567 | 1,368 | 1,457 | 1,588 | 1,134 | |||
| Other undisclosed accounts payable and accrued liabilities | (530) | (981) | (476) | (762) | |||||
| Debt | 6 | 6 | 304 | 50 | |||||
| Other liabilities | 358 | 300 | 298 | ||||||
| Other undisclosed current liabilities | 166 | 678 | 476 | 464 | |||||
| Total current liabilities: | 2,257 | 2,340 | 1,898 | 2,441 | 2,368 | 1,946 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 134 | 137 | 141 | 485 | 681 | 485 | |||
| Long-term debt, excluding current maturities | 134 | 137 | 141 | 144 | 276 | ||||
| Liabilities, other than long-term debt | 26 | 104 | 228 | 16 | 15 | 16 | |||
| Other liabilities | 16 | 20 | 21 | 16 | 15 | 16 | |||
| Operating lease, liability | 10 | 84 | 207 | 341 | 405 | 485 | |||
| Total noncurrent liabilities: | 160 | 241 | 369 | 501 | 696 | 501 | |||
| Total liabilities: | 2,417 | 2,581 | 2,267 | 2,942 | 3,064 | 2,447 | |||
| Equity | |||||||||
| Equity, attributable to parent, including: | 6,330 | 7,321 | 14,911 | 23,892 | (76,917) | (68,217) | |||
| Accumulated other comprehensive loss | (3,496) | (3,423) | (3,389) | (2,968) | (2,774) | (2,850) | |||
| Accumulated deficit | (120,744) | (113,665) | (100,665) | (89,159) | (74,143) | (65,367) | |||
| Other undisclosed equity, attributable to parent | 130,570 | 124,409 | 118,965 | 116,019 | |||||
| Other undisclosed equity | 109,720 | 94,754 | |||||||
| Total equity: | 6,330 | 7,321 | 14,911 | 23,892 | 32,803 | 26,537 | |||
| TOTAL LIABILITIES AND EQUITY: | 8,747 | 9,902 | 17,178 | 26,834 | 35,867 | 28,984 | |||
Income Statement (P&L) ($ in thousands)
| 9/30/2025 TTM | 3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 1,271 | 1,345 | 911 | 397 | 898 | 4,072 | ||
| Cost of revenue | (652) | (612) | (469) | (203) | (785) | (3,957) | ||
| Cost of product and service sold | (217) | (1,000) | (376) | (252) | (307) | |||
| Gross profit: | 619 | 733 | 442 | 194 | 113 | 115 | ||
| Operating expenses | (8,065) | (10,531) | (12,013) | (15,622) | (8,837) | (6,979) | ||
| Operating loss: | (7,446) | (9,798) | (11,571) | (15,428) | (8,724) | (6,864) | ||
| Nonoperating income (Other Nonoperating income) | 325 | 143 | 65 | 461 | 82 | 331 | ||
| Interest and debt expense | (5) | (5) | (5) | 430 | (3) | |||
| Other undisclosed loss from continuing operations before equity method investments, income taxes | (166) | (782) | ||||||
| Loss from continuing operations before equity method investments, income taxes: | (7,126) | (9,660) | (11,511) | (14,537) | (8,811) | (7,315) | ||
| Other undisclosed income (loss) from continuing operations before income taxes | 5 | (3,340) | 5 | (479) | ||||
| Loss from continuing operations: | (7,121) | (13,000) | (11,506) | (15,016) | (8,811) | (7,315) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | (15,016) | (8,811) | (7,315) | |
| Net loss: | (7,121) | (13,000) | (11,506) | (15,016) | (8,811) | (7,315) | ||
| Other undisclosed net loss attributable to parent | (1) | |||||||
| Net loss available to common stockholders, basic: | (7,122) | (13,000) | (11,506) | (15,016) | (8,811) | (7,315) | ||
| Dilutive securities, effect on basic earnings per share | ||||||||
| Net income (loss) available to common stockholders, diluted: | (7,122) | (13,000) | (11,506) | (15,016) | (8,811) | (7,315) | ||
Comprehensive Income ($ in thousands)
| 9/30/2025 TTM | 3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (7,121) | (13,000) | (11,506) | (15,016) | (8,811) | (7,315) | ||
| Comprehensive loss: | (7,121) | (13,000) | (11,506) | (15,016) | (8,811) | (7,315) | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (30) | (34) | (421) | (194) | 76 | (431) | ||
| Comprehensive loss, net of tax, attributable to parent: | (7,151) | (13,034) | (11,927) | (15,210) | (8,735) | (7,746) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.